Total Payments
$29,338
2024 Payments
$17,438
Companies
15
Transactions
308
Medicare Patients
421
Medicare Billing
$16,133
Payment Breakdown by Category
Other$21,086 (71.9%)
Food & Beverage$5,719 (19.5%)
Travel$2,533 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,086 | 18 | 71.9% |
| Food and Beverage | $5,719 | 274 | 19.5% |
| Travel and Lodging | $2,533 | 16 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $25,319 | 105 | $0 (2024) |
| ITI, Inc. | $1,023 | 50 | $0 (2023) |
| Alkermes, Inc. | $520.96 | 12 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $511.64 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $434.31 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $375.37 | 23 | $0 (2023) |
| ABBVIE INC. | $352.77 | 31 | $0 (2024) |
| Lundbeck LLC | $240.91 | 12 | $0 (2024) |
| Corium, LLC | $225.61 | 7 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $132.88 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,438 | 61 | Otsuka America Pharmaceutical, Inc. ($17,153) |
| 2023 | $8,364 | 53 | Otsuka America Pharmaceutical, Inc. ($7,750) |
| 2022 | $2,272 | 120 | ITI, Inc. ($650.70) |
| 2021 | $1,264 | 74 | Alkermes, Inc. ($305.67) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $206.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,695.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $177.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $109.95 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,695.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,428.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $82.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | In-kind items and services | $136.55 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | In-kind items and services | $136.55 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $66.69 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $402.50 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 66 | 91 | $6,860 | $1,823 |
| 2021 | 2 | 94 | 208 | $15,330 | $6,401 |
| 2020 | 3 | 261 | 379 | $26,510 | $7,910 |
Total Patients
421
Total Services
678
Medicare Billing
$16,133
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 21 | $1,960 | $701.87 | 35.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 23 | 41 | $2,870 | $679.29 | 23.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 28 | 29 | $2,030 | $441.42 | 21.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 72 | 164 | $11,760 | $5,013 | 42.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 22 | 44 | $3,570 | $1,388 | 38.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 81 | 150 | $10,990 | $3,957 | 36.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 44 | 52 | $3,780 | $1,441 | 38.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 38 | 56 | $4,410 | $937.24 | 21.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 57 | $4,130 | $817.76 | 19.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 49 | 64 | $3,200 | $756.77 | 23.6% |
About Keri Barr, PMHNP
Keri Barr, PMHNP is a Psychiatric/Mental Health healthcare provider based in Bay Minette, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1215300736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Keri Barr, PMHNP has received a total of $29,338 in payments from pharmaceutical and medical device companies, with $17,438 received in 2024. These payments were reported across 308 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,086).
As a Medicare-enrolled provider, Barr has provided services to 421 Medicare beneficiaries, totaling 678 services with total Medicare billing of $16,133. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Bay Minette, AL
- Active Since 11/05/2015
- Last Updated 05/10/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1215300736
Products in Payments
- ABILIFY MAINTENA (Drug) $14,771
- ABILIFY ASIMTUFII (Drug) $9,953
- CAPLYTA (Drug) $1,103
- REXULTI (Drug) $835.59
- INGREZZA (Drug) $434.31
- AUSTEDO (Drug) $368.58
- INVEGA SUSTENNA (Drug) $357.70
- VRAYLAR (Drug) $352.77
- LYBALVI (Drug) $337.70
- AZSTARYS (Drug) $206.31
- ARISTADA (Drug) $183.26
- UZEDY (Drug) $143.06
- LATUDA (Drug) $132.88
- PERSERIS (Drug) $59.35
- Auvelity (Drug) $25.29
- Azstarys (Drug) $19.30
- SPRAVATO (Drug) $17.67
- QELBREE (Drug) $14.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.